Thymosin Alpha-1

Thymosin Alpha-1 is a peptide that comes from the thymus, the gland that trains immune cells. It helps certain immune cells mature and respond.

It's studied in immune and longevity research — how the body fights infections and how immune cells are activated.

It's approved in many countries for chronic hepatitis and as a vaccine helper. Its immune effects are documented; uses in the U.S. are limited.

Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.

Thymosin Alpha-1 has FDA Orphan Drug status for specific conditions. BBOHC material is a research reagent only.

BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.

Generally well tolerated in clinical literature.

• Matteucci C et al. Thymosin alpha 1 empowers dendritic cells. Ann N Y Acad Sci. 2012.

Specific citations are provided for literature context. Product purity & lot verification documentation available on request.